Skip to Content

Join the 'GoNitro' group to help and get support from people like you.

GoNitro News

Espero Pharmaceuticals Receives FDA Approval for GoNitro (nitroglycerin) Sublingual Powder

Posted 22 Jun 2016 by Drugs.com

JACKSONVILLE, Fla. (June 14, 2016) – Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved GoNitro (nitroglycerin) sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. With this approval, GoNitro is the first and only short-acting nitrate in a stabilized crystal granule form available in single dose packets. “The FDA’s approval of GoNitro enhances the treatment options available to the more than 8 million U.S. patients suffering with stable angina due to coronary artery disease (CAD), the most common type of heart disease,” commented Quang Pham, Founder and CEO of Espero Pharmaceuticals. “GoNitro is a sublingual nitrate and as this class of drug therapy is a Class I recommendation according to the 2012 Stable Ischemic Heart ... Read more

Related support groups: Angina, Nitroglycerin, Angina Pectoris Prophylaxis, GoNitro

Ask a Question

Further Information

Related Condition Support Groups

Angina, Angina Pectoris Prophylaxis

GoNitro Patient Information at Drugs.com